4/24/2012IDSA Supports Senate Antibiotics Legislation (PDF)
The Society supports provisions in the legislation that would help address the dry antibiotic research and development pipeline.
4/12/2012IDSA Urges Congress to Create New Antibiotic Approval Pathway (PDF)
The Society’s proposed Limited Population Antibacterial Drug (LPAD) mechanism would streamline the development of antibiotics needed to treat the most serious infections.
3/28/2012IDSA, Physician Groups Urge CMS to Reevaluate Penalty Timelines (PDF)
The simultaneous implementation of multiple programs, such as penalties under the electronic prescribing program and others, will create a burden on physician practices.
3/15/2012Leading ID Experts Call for Increased Focus on Protecting Antibiotics
IDSA, SHEA, and PIDS urge health care systems and policymakers to step up efforts to protect patients by preserving the effectiveness of available antibiotics through antimicrobial stewardship.
3/15/2012Patient-Centered Outcomes Research Agenda Should Include ID (PDF)
IDSA urged the Patient-Centered Outcomes Research Institute to consider ID areas that align with the institute’s priorities and where there are gaps in current evidence that would benefit from this research.
3/8/2012New Antibiotic Approval Pathway Would Address Critical Need (PDF)
In testimony to Congress, IDSA proposed a new approval pathway for anti-infective therapies for serious resistant infections where few treatments are available.
2/22/201250 Groups Urge Congress to Enact Antibiotic Development Incentives (PDF)
Lawmakers should adopt economic incentives to address the dry antibiotic research and development pipeline.
1 of 8